Evidence map›Paper›PMID 17075687›Full record

ReviewJournal of mammary gland biology and neoplasia2006

Current and future use of positron emission tomography (PET) in breast cancer.

David A Mankoff, William B Eubank

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of mammary gland biology and neoplasia, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David A MankoffDivision of Nuclear Medicine, Department of Radiology, University of Washington and Seattle Cancer Care Alliance, Seattle, WA, USA.
William B Eubank

Funding

IMAGING THE RESPONSE OF LOCALLY ADVANCED BREAST CANCERR01CA072064 · NCI · UNIVERSITY OF WASHINGTON · PI MANKOFF, DAVID A. · 1996 to 2006
$3.1M
Diagnosis of IM Nodal Metastases in Breast CancerR01CA090771 · NCI · UNIVERSITY OF WASHINGTON · PI MANKOFF, DAVID A · 2001 to 2004
$1.6M
NCI NIH HHS R01CA42045NCI NIH HHS R01CA72064NCI NIH HHS R01CA90771NCRR NIH HHS S10RR177229
6 · The paper itself

Abstract

Positron emission tomography (PET) is a radiotracer imaging method that is increasingly used in both the clinical care of breast cancer patients and in translational breast cancer research. This review emphasizes current and future clinical applications of PET to breast cancer, and highlights some translational research using PET to elucidate the clinical biology of breast cancer. PET principles are reviewed, followed by a review of current applications of (18)F-fluorodeoxyglucose (FDG) to clinical breast cancer care. Finally we review work done with other radiopharmaceuticals beyond FDG designed to image a number of aspects of breast cancer biology, emphasizing those most likely to enter clinical trials in the near future.

Indexed as

Fluorodeoxyglucose F18Breast NeoplasmsFemaleForecastingHumansLymphatic MetastasisLymph NodesNeoplasm Recurrence, LocalNeoplasm StagingPositron-Emission TomographyPreoperative CarePrognosisSensitivity and SpecificitySentinel Lymph Node BiopsyFluorodeoxyglucose F18

Identifiers

PMID17075687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.